These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 34541635
1. Vigabatrin - new data on indications and safety in paediatric epilepsy. Golec W, Sołowiej E, Strzelecka J, Jurkiewicz E, Jóźwiak S. Neurol Neurochir Pol; 2021; 55(5):429-439. PubMed ID: 34541635 [Abstract] [Full Text] [Related]
2. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile. Camposano SE, Major P, Halpern E, Thiele EA. Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386 [Abstract] [Full Text] [Related]
3. [Efficacy of vigabatrin therapy for tuberous sclerosis with infantile spasms]. Suzuki-Muromoto, S, Uematsu M, Sato H, Numata-Uematsu Y, Nakayama T, Kiluchi A, Kobayashi T, Hino-Fukuyo N, Kure S. No To Hattatsu; 2016 Nov; 48(6):413-9. PubMed ID: 30010289 [Abstract] [Full Text] [Related]
4. The role of vigabatrin in childhood seizure disorders: results from a clinical audit. Prasad AN, Penney S, Buckley DJ. Epilepsia; 2001 Jan; 42(1):54-61. PubMed ID: 11207785 [Abstract] [Full Text] [Related]
6. Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review. Prezioso G, Chiarelli F, Matricardi S. Expert Rev Neurother; 2023 Sep; 23(7):661-671. PubMed ID: 37243682 [Abstract] [Full Text] [Related]
7. [Effectiveness of vigabatrin in west syndrome associated with tuberous sclerosis]. Ando N, Fujimoto S, Ishikawa T, Kobayashi S, Hattori A, Ito T, Togari H. No To Hattatsu; 2010 Nov; 42(6):444-8. PubMed ID: 21077355 [Abstract] [Full Text] [Related]
8. High vigabatrin dosage is associated with lower risk of infantile spasms relapse among children with tuberous sclerosis complex. Hussain SA, Schmid E, Peters JM, Goyal M, Bebin EM, Northrup H, Sahin M, Krueger DA, Wu JY, Tuberous Sclerosis Complex Autism Center of Excellence Network. Epilepsy Res; 2018 Dec; 148():1-7. PubMed ID: 30296632 [Abstract] [Full Text] [Related]
9. Vigabatrin-related adverse events for the treatment of epileptic spasms: systematic review and meta-analysis. Biswas A, Yossofzai O, Vincent A, Go C, Widjaja E. Expert Rev Neurother; 2020 Dec; 20(12):1315-1324. PubMed ID: 33078964 [Abstract] [Full Text] [Related]
19. Vigabatrin for Epileptic Spasms and Tonic Seizures in Tuberous Sclerosis Complex. van der Poest Clement EA, Sahin M, Peters JM. J Child Neurol; 2018 Jul; 33(8):519-524. PubMed ID: 29687739 [Abstract] [Full Text] [Related]